Literature DB >> 940652

Fetal and neonatal cardiopulmonary response to histamine.

J R Woods, C R Brinkman, N S Assali.   

Abstract

Effects of intravenous histamine and its H1 receptor blocker (Benadryl) were investigated in near-term fetal and in newborn lambs. Fetuses were studied before and after closure of the ductus arteriosus. Newborn lambs were chronically instrumented and the same animal was tested periodically from 3 to 70 days old. The results show that a) in the fetus whose pulmonary vascular resistance is already high, histamine produces a profound pulmonary vasodilation; b) in contrast, in the neonate with reduced pulmonary vascular resistance, histamine produces pulmonary vasoconstriction similar to that of the adult; c) both responses can be attenuated by Benadryl indicating that they are mediated by the same receptor; d) in the fetus, histamine produces marked constriction of the ductus arteriosus which could be partly attributed to the pulmonary vasocilatation; and e) when neonatal pulmonary vascular resistance was raised by hypoxia, histamine elicited a biphasic response, part of which was blocked by Benadryl. These findings are discussed in terms of their possible role in cardiovascular and pulmonary changes that occur after birth.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 940652

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.

Authors:  Robert B Cotton; Lisa P Shah; Stanley D Poole; Noah J Ehinger; Naoko Brown; Elaine L Shelton; James C Slaughter; H Scott Baldwin; Bibhash C Paria; Jeff Reese
Journal:  J Mol Cell Cardiol       Date:  2013-02-27       Impact factor: 5.000

2.  Pulmonary and systemic vascular response to promethazine in conscious lambs.

Authors:  R F Covert; W H Drummond; I B Webb; P A Gimotty
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.